Sequal Eclipse 3

Sequal Eclipse 3

sequal Eclipse 3

Download the Eclipse Oxygen Portable Brochure

The Eclipse 3 is a single solution for both a portable and in-home oxygen concentrator

  • Offers both continuous flow and pulse dosing options
  • One machine for stationary, ambulatory and travel needs
  • Lower operational costs by reducing monthly deliveries and simplifying inventory management
  • Maximum Medicare reimbursement with two billing codes: E1390 & E1392
  • Longer service intervals with lower maintenance costs
  • The only system on the market that can be upgraded in the field as new technology becomes available

Patients want the freedom to enjoy life at a moment’s notice and the peace of mind that the reliable Eclipse 3 delivers.

It keeps up with the various activities of daily living while providing the individualized oxygen prescription.

  • Active and healthier patients create stronger referrals
  • Simplifies the patients’ continuum of care with one device
  • No waiting for cylinder deliveries and replaces bulky equipment
  • The sleek design is small, quiet and can lower electric bills
  • AC/DC and battery power options extend therapy time and patient travel
  • FAA Approved for commercial airline travel
  • Accessory options that support an active lifestyle

Proven. The AARC suggests “titrate to saturate” and the Eclipse was developed with that theory in mind. With a comprehensive dosing selection, a broader patient population can be treated at rest, during sleep, at exercise and at altitude. It’s superior oxygen delivery.

  • autoSAT Technology, a pulse delivery system, maintains a consistent pulse dose volume for every breath as your patient’s respiratory rate changes
  • Consistently delivers a fixed pulse dose volume up to 96mL (in increments of 16mL) in addition, three new pulse dose volumes of 128mL, 160mL and 192mL
  • New control panel displays in either LPM or mL for a more accurate prescription verification
  • Can be used with CPAP and bi-level devices in Continuous Flow


No Comments

Sorry, the comment form is closed at this time.